title: Can HIV-1 superinfection compromise antiretroviral therapy?
authors.forename: Bikram
authors.initials: B
authors.lastname: Chakraborty
authors.forename: Patti
authors.initials: P
authors.lastname: Kiser
authors.forename: Hector R
authors.initials: HR
authors.lastname: Rangel
authors.forename: Jan
authors.initials: J
authors.lastname: Weber
authors.forename: Muneer
authors.initials: M
authors.lastname: Mirza
authors.forename: Michael L
authors.initials: ML
authors.lastname: Marotta
authors.forename: Robert
authors.initials: R
authors.lastname: Asaad
authors.forename: Benigno
authors.initials: B
authors.lastname: Rodriguez
authors.forename: Hernan
authors.initials: H
authors.lastname: Valdez
authors.forename: Michael M
authors.initials: MM
authors.lastname: Lederman
authors.forename: Miguel E
authors.initials: ME
authors.lastname: Quiñones-Mateu
mesh_terms: D000595:Amino Acid Sequence; D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008969:Molecular Sequence Data; D015163:Superinfection / Q000276:immunology*
chemical_list: D044966:Anti-Retroviral Agents